Summary
The government plans to address regulatory gaps in drug deals after discovering drugmakers concealed licence cancellations to secure supply orders. New mandates will require states to display licence cancellation information on their websites and share it monthly with the Central Drugs Standard Control Organisation to ensure quality medicines.